Fusion Pharmaceuticals Stock (NASDAQ: FUSN) stock price, news, charts, stock research, profile.
Open | $21.370 |
Close | $21.420 |
Volume / Avg. | 351.216K / 2.158M |
Day Range | 21.370 - 21.480 |
52 Wk Range | 2.310 - 21.550 |
Market Cap | $1.813B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 80 |
Short Interest | 7.19% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fusion Pharmaceuticals (NASDAQ: FUSN) through any online brokerage.
Other companies in Fusion Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Fusion Pharmaceuticals (NASDAQ: FUSN) was reported by TD Cowen on Tuesday, April 16, 2024. The analyst firm set a price target for 0.00 expecting FUSN to fall to within 12 months (a possible -100.00% downside). 27 analyst firms have reported ratings in the last year.
The stock price for Fusion Pharmaceuticals (NASDAQ: FUSN) is $21.36 last updated April 25, 2024 at 5:13 PM EDT.
There are no upcoming dividends for Fusion Pharmaceuticals.
Fusion Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Fusion Pharmaceuticals.
Fusion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.